ADMA Biologics Inc (ADMA)
9.105
-0.06
(-0.60%)
USD |
NASDAQ |
May 15, 16:00
9.105
0.00 (0.00%)
After-Hours: 16:06
ADMA Biologics Accounts Receivable (Quarterly): 49.62M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 49.62M |
December 31, 2023 | 27.42M |
September 30, 2023 | 31.32M |
June 30, 2023 | 36.73M |
March 31, 2023 | 26.52M |
December 31, 2022 | 15.50M |
September 30, 2022 | 20.90M |
June 30, 2022 | 18.88M |
March 31, 2022 | 25.63M |
December 31, 2021 | 28.58M |
September 30, 2021 | 20.39M |
June 30, 2021 | 23.54M |
March 31, 2021 | 15.36M |
December 31, 2020 | 13.24M |
September 30, 2020 | 6.334M |
June 30, 2020 | 6.514M |
March 31, 2020 | 7.108M |
December 31, 2019 | 3.470M |
September 30, 2019 | 7.316M |
June 30, 2019 | 5.087M |
March 31, 2019 | 1.310M |
December 31, 2018 | 1.392M |
September 30, 2018 | 4.127M |
June 30, 2018 | 3.797M |
Date | Value |
---|---|
March 31, 2018 | 3.658M |
December 31, 2017 | 3.880M |
September 30, 2017 | 1.500M |
June 30, 2017 | 2.292M |
March 31, 2017 | 0.8399M |
December 31, 2016 | 1.018M |
September 30, 2016 | 1.328M |
June 30, 2016 | 0.8267M |
March 31, 2016 | 0.9439M |
December 31, 2015 | 0.9245M |
September 30, 2015 | 1.201M |
June 30, 2015 | 0.5225M |
March 31, 2015 | 0.3514M |
December 31, 2014 | 0.384M |
September 30, 2014 | 0.5622M |
June 30, 2014 | 0.8035M |
March 31, 2014 | 0.4844M |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.3351M |
June 30, 2013 | 0.2369M |
March 31, 2013 | 0.3263M |
December 31, 2012 | 0.0391M |
September 30, 2012 | 0.0619M |
June 30, 2012 | 0.2201M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
3.470M
Minimum
Dec 2019
49.62M
Maximum
Mar 2024
19.47M
Average
19.64M
Median
Accounts Receivable (Quarterly) Benchmarks
Vanda Pharmaceuticals Inc | 36.71M |
ANI Pharmaceuticals Inc | 172.42M |
Ligand Pharmaceuticals Inc | 28.44M |
Johnson & Johnson | 14.95B |
Puma Biotechnology Inc | 24.58M |